Holterman, L., Vogels, R., van der Vlugt, R., Sieuwerts, M., Grimbergen, J., Kaspers, J., . . . Havenga, M. (2004). Novel Replication-Incompetent Vector Derived from Adenovirus Type 11 (Ad11) for Vaccination and Gene Therapy: Low Seroprevalence and Non-Cross-Reactivity with Ad5. American Society for Microbiology.
Chicago-stil citatHolterman, Lennart, et al. Novel Replication-Incompetent Vector Derived From Adenovirus Type 11 (Ad11) for Vaccination and Gene Therapy: Low Seroprevalence and Non-Cross-Reactivity With Ad5. American Society for Microbiology, 2004.
MLA-referensHolterman, Lennart, et al. Novel Replication-Incompetent Vector Derived From Adenovirus Type 11 (Ad11) for Vaccination and Gene Therapy: Low Seroprevalence and Non-Cross-Reactivity With Ad5. American Society for Microbiology, 2004.